315 related articles for article (PubMed ID: 23957008)
1. Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era.
Chen J; Zhang D; Yan W; Yang D; Shen B
Biomed Res Int; 2013; 2013():901578. PubMed ID: 23957008
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
3. A modern era of personalized medicine in the diagnosis, prognosis, and treatment of prostate cancer.
Lakshmanan VK; Ojha S; Jung YD
Comput Biol Med; 2020 Nov; 126():104020. PubMed ID: 33039808
[TBL] [Abstract][Full Text] [Related]
4. Next generation mapping reveals novel large genomic rearrangements in prostate cancer.
Jaratlerdsiri W; Chan EKF; Petersen DC; Yang C; Croucher PI; Bornman MSR; Sheth P; Hayes VM
Oncotarget; 2017 Apr; 8(14):23588-23602. PubMed ID: 28423598
[TBL] [Abstract][Full Text] [Related]
5. Critical role of bioinformatics in translating huge amounts of next-generation sequencing data into personalized medicine.
Hong H; Zhang W; Shen J; Su Z; Ning B; Han T; Perkins R; Shi L; Tong W
Sci China Life Sci; 2013 Feb; 56(2):110-8. PubMed ID: 23393026
[TBL] [Abstract][Full Text] [Related]
6. Current Challenges and Implications of Proteogenomic Approaches in Prostate Cancer.
Shukla N; Siva N; Malik B; Suravajhala P
Curr Top Med Chem; 2020; 20(22):1968-1980. PubMed ID: 32703135
[TBL] [Abstract][Full Text] [Related]
7. ASEQ: fast allele-specific studies from next-generation sequencing data.
Romanel A; Lago S; Prandi D; Sboner A; Demichelis F
BMC Med Genomics; 2015 Mar; 8():9. PubMed ID: 25889339
[TBL] [Abstract][Full Text] [Related]
8. Sequencing the transcriptional network of androgen receptor in prostate cancer.
Chng KR; Cheung E
Cancer Lett; 2013 Nov; 340(2):254-60. PubMed ID: 23196061
[TBL] [Abstract][Full Text] [Related]
9. Whole Exome Sequencing Identifies Putative Predictors of Recurrent Prostate Cancer with High Accuracy.
Liu J; Mao R; Ren G; Liu X; Zhang Y; Wang J; Wang Y; Li M; Qiu Q; Wang L; Liu G; Jin S; Ma L; Ma Y; Zhao N; Yan J; Zhang H; Lin B
OMICS; 2019 Aug; 23(8):380-388. PubMed ID: 31194651
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment.
Yadav SS; Li J; Lavery HJ; Yadav KK; Tewari AK
Urol Oncol; 2015 Jun; 33(6):267.e1-13. PubMed ID: 25791755
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer epigenetic biomarkers: next-generation technologies.
Valdés-Mora F; Clark SJ
Oncogene; 2015 Mar; 34(13):1609-18. PubMed ID: 24837368
[TBL] [Abstract][Full Text] [Related]
12. New strategies in prostate cancer: translating genomics into the clinic.
Beltran H; Rubin MA
Clin Cancer Res; 2013 Feb; 19(3):517-23. PubMed ID: 23248095
[TBL] [Abstract][Full Text] [Related]
13. Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.
Seed G; Yuan W; Mateo J; Carreira S; Bertan C; Lambros M; Boysen G; Ferraldeschi R; Miranda S; Figueiredo I; Riisnaes R; Crespo M; Rodrigues DN; Talevich E; Robinson DR; Kunju LP; Wu YM; Lonigro R; Sandhu S; Chinnaiyan AM; de Bono JS
Clin Cancer Res; 2017 Oct; 23(20):6070-6077. PubMed ID: 28751446
[No Abstract] [Full Text] [Related]
14. Bioinformatics Resources for Plant Genomics: Opportunities and Bottlenecks in The -omics Era.
Ambrosino L; Colantuono C; Monticolo F; Chiusano ML
Curr Issues Mol Biol; 2018; 27():71-88. PubMed ID: 28885175
[TBL] [Abstract][Full Text] [Related]
15. The Genomics of Prostate Cancer: A Historic Perspective.
Rubin MA; Demichelis F
Cold Spring Harb Perspect Med; 2019 Mar; 9(3):. PubMed ID: 29712681
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing.
Ikeda S; Elkin SK; Tomson BN; Carter JL; Kurzrock R
Cancer Biol Ther; 2019; 20(2):219-226. PubMed ID: 30339521
[TBL] [Abstract][Full Text] [Related]
17. Novel bioinformatic developments for exome sequencing.
Lelieveld SH; Veltman JA; Gilissen C
Hum Genet; 2016 Jun; 135(6):603-14. PubMed ID: 27075447
[TBL] [Abstract][Full Text] [Related]
18. Next Generation Sequencing and Bioinformatics Methodologies for Infectious Disease Research and Public Health: Approaches, Applications, and Considerations for Development of Laboratory Capacity.
Maljkovic Berry I; Melendrez MC; Bishop-Lilly KA; Rutvisuttinunt W; Pollett S; Talundzic E; Morton L; Jarman RG
J Infect Dis; 2020 Mar; 221(Suppl 3):S292-S307. PubMed ID: 31612214
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification.
Schoenborn JR; Nelson P; Fang M
Clin Cancer Res; 2013 Aug; 19(15):4058-66. PubMed ID: 23704282
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Commercial Next-Generation Sequencing Bioinformatics Software Solutions.
Gullapalli RR
J Mol Diagn; 2020 Feb; 22(2):147-158. PubMed ID: 31751676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
